In aggressive thyroid cancer, there was significant reduction in overall biotinidase expression (p = 0.001) at both nuclear (p<0.001) and cytoplasmic (p = 0.002) levels as compared to non-aggressive thyroid tumors (Table 1, Figures 1c and 2). This evidence concerns the gene BTD and thyroid tumor.